Mohammed Fakhro1, Richard Ingemansson1, Ingrid Skog2, Lars Algotsson3, Lennart Hansson2, Bansi Koul1, Ronny Gustafsson1, Per Wierup1, Sandra Lindstedt4. 1. Department of Cardiothoracic Surgery, Skåne University Hospital, Lund University, Lund, Sweden. 2. Department of Pulmonary Medicine, Skåne University Hospital, Lund University, Lund, Sweden. 3. Department of Thoracic Intensive Care and Anesthesia, Skåne University Hospital, Lund University, Lund, Sweden. 4. Department of Cardiothoracic Surgery, Skåne University Hospital, Lund University, Lund, Sweden sandra.lindstedt.ingemansson@gmail.com.
Abstract
OBJECTIVES: In Sweden, two centres perform lung transplantation for a population of about 9 million and the entire population is covered for lung transplantation by government health insurance. Lund University Hospital is one of these centres. This retrospective report reviews the 25-year experience of the Skåne University Hospital Lung Transplant Program with particular emphasis on short-term outcome and long-term survival but also between different subgroups of patients and types of transplant [single-lung transplantation (SLTx) versus double-lung transplantation (DLTx)] procedure performed. METHODS: Between January 1990 and June 2014, 278 patients underwent lung transplantation at the Skåne University Hospital Sweden. DLTx was performed in 172 patients, SLTx was performed in 97 patients and heart-lung transplantation was performed in 9 patients. In addition, 15 patients required retransplantation (7 DLTx and 8 SLTx). RESULTS: Overall 1-, 5-, 10-, 15- and 20-year survival rates were 88, 65, 49, 37 and 19% for the whole cohort. DLTx recipients showed 1-, 5-, 10- and 20-year survival rates of 90, 71, 60 and 30%, compared with SLTx recipients with 1-, 5-, 10- and 20-year survival rates of 83, 57, 34 and 6% (P < 0.05), respectively. Comparing the use of intraoperative extracorporeal membrane oxygenation, extracorporeal circulation (ECC) and no circulatory support in the aspect of survival, a significant difference in favour of intraoperative ECC was seen. CONCLUSIONS: Superior long-term survival rates were seen in recipients diagnosed with cystic fibrosis, α1-antitrypsin deficiency and pulmonary hypertension. DLTx showed better results compared with SLTx especially at 10 years post-transplant. In the present study, we present cumulative incidence rates of bronchiolitis obliterans syndrome of 15% at 5 years, 26% at 10 years and 32% at 20 years post-transplant; these figures are in line with the lowest rates presented internationally.
OBJECTIVES: In Sweden, two centres perform lung transplantation for a population of about 9 million and the entire population is covered for lung transplantation by government health insurance. Lund University Hospital is one of these centres. This retrospective report reviews the 25-year experience of the Skåne University Hospital Lung Transplant Program with particular emphasis on short-term outcome and long-term survival but also between different subgroups of patients and types of transplant [single-lung transplantation (SLTx) versus double-lung transplantation (DLTx)] procedure performed. METHODS: Between January 1990 and June 2014, 278 patients underwent lung transplantation at the Skåne University Hospital Sweden. DLTx was performed in 172 patients, SLTx was performed in 97 patients and heart-lung transplantation was performed in 9 patients. In addition, 15 patients required retransplantation (7 DLTx and 8 SLTx). RESULTS: Overall 1-, 5-, 10-, 15- and 20-year survival rates were 88, 65, 49, 37 and 19% for the whole cohort. DLTx recipients showed 1-, 5-, 10- and 20-year survival rates of 90, 71, 60 and 30%, compared with SLTx recipients with 1-, 5-, 10- and 20-year survival rates of 83, 57, 34 and 6% (P < 0.05), respectively. Comparing the use of intraoperative extracorporeal membrane oxygenation, extracorporeal circulation (ECC) and no circulatory support in the aspect of survival, a significant difference in favour of intraoperative ECC was seen. CONCLUSIONS: Superior long-term survival rates were seen in recipients diagnosed with cystic fibrosis, α1-antitrypsin deficiency and pulmonary hypertension. DLTx showed better results compared with SLTx especially at 10 years post-transplant. In the present study, we present cumulative incidence rates of bronchiolitis obliterans syndrome of 15% at 5 years, 26% at 10 years and 32% at 20 years post-transplant; these figures are in line with the lowest rates presented internationally.
Authors: Marshall I Hertz; David O Taylor; Elbert P Trulock; Mark M Boucek; Paul J Mohacsi; Leah B Edwards; Berkeley M Keck Journal: J Heart Lung Transplant Date: 2002-09 Impact factor: 10.247
Authors: C Ashley Finlen Copeland; Laurie D Snyder; David W Zaas; W Jackson Turbyfill; W Austin Davis; Scott M Palmer Journal: Am J Respir Crit Care Med Date: 2010-05-27 Impact factor: 21.405
Authors: Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2010-10 Impact factor: 10.247
Authors: Jonathan B Orens; Marc Estenne; Selim Arcasoy; John V Conte; Paul Corris; Jim J Egan; Thomas Egan; Shaf Keshavjee; Christiane Knoop; Robert Kotloff; Fernando J Martinez; Steven Nathan; Scott Palmer; Alec Patterson; Lianne Singer; Gregory Snell; Sean Studer; J L Vachiery; Allan R Glanville Journal: J Heart Lung Transplant Date: 2006-07 Impact factor: 10.247
Authors: Christopher M Burton; Jørn Carlsen; Jann Mortensen; Claus B Andersen; Nils Milman; Martin Iversen Journal: J Heart Lung Transplant Date: 2007-07 Impact factor: 10.247
Authors: Christopher M Burton; Martin Iversen; Jørn Carlsen; Jann Mortensen; Claus B Andersen; Daniel Steinbrüchel; Thomas Scheike Journal: J Heart Lung Transplant Date: 2009-09 Impact factor: 10.247
Authors: Christopher M Burton; Nils Milman; Jørn Carlsen; Henrik Arendrup; Kirsten Eliasen; Claus B Andersen; Martin Iversen Journal: J Heart Lung Transplant Date: 2005-06-20 Impact factor: 10.247
Authors: Christopher M Burton; Martin Iversen; Jann Mortensen; Jørn Carlsen; Claus B Andersen; Nils Milman; Thomas Scheike Journal: J Heart Lung Transplant Date: 2007-09-29 Impact factor: 10.247
Authors: Rudolf Speich; Laurent Pierre Nicod; John-David Aubert; Anastase Spiliopoulos; John Wellinger; John Henri Robert; Reto Stocker; Marco Zalunardo; Paola Gasche-Soccal; Annette Boehler; Walter Weder Journal: Swiss Med Wkly Date: 2004-01-10 Impact factor: 2.193
Authors: Mohammed Fakhro; Ellen Broberg; Lars Algotsson; Lennart Hansson; Bansi Koul; Ronny Gustafsson; Per Wierup; Richard Ingemansson; Sandra Lindstedt Journal: J Cardiothorac Surg Date: 2017-11-25 Impact factor: 1.637